Vireo Growth Inc. (CSE: VREO)
Canada
· Delayed Price · Currency is CAD
0.790
+0.010 (1.28%)
Dec 20, 2024, 2:45 PM EST
Vireo Growth Company Description
Vireo Growth Inc. operates as a cannabis company in the United States.
The company cultivates, manufactures, processes, and distributes medical and adult-use cannabis products.
It sells cannabis products through its network of Green Goods and other Goodness Growth branded retail dispensaries and third-party dispensaries in Maryland, Minnesota, and New York.
The company was formerly known as Goodness Growth Holdings, Inc. and changed its name to Vireo Growth Inc. in July 2024.
Vireo Growth Inc. is headquartered in Minneapolis, Minnesota.
Vireo Growth Inc.
Country | Canada |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 490 |
CEO | John Mazarakis |
Contact Details
Address: 207 South Ninth Street Minneapolis, British Columbia 55402 United States | |
Phone | 612 999 1606 |
Website | vireogrowth.com |
Stock Details
Ticker Symbol | VREO |
Exchange | Canadian Securities Exchange |
Fiscal Year | January - December |
Reporting Currency | USD |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Dr. Kyle E. Kingsley | Founder, Chairman and Chief Executive Officer |
John A. Heller | Chief Financial Officer |
Christian Gonzalez Ocasio | Chief Operating Officer |
Amber H. Shimpa | Chief Administrative Officer and Director |
Sam Gibbons | Vice President of Investor Relations |
J. Michael Schroeder | Chief Compliance Officer, Company Secretary and General Counsel |
Dr. Stephen M. Dahmer M.D. | Chief Medical Officer |
Patrick Peters | Executive Vice President of Retail |